The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients. X-linked retinitis pigmentosa, caused by mutations in RPGR gene, is the most common cause of blindness in young people. The inherited mutations lead to degeneration of light… Read More »
Losing one’s memories, and therefore one’s identity, must be a terrifying experience. With a global estimate of almost 50 million people living with dementia, predicted to rise to more than 130 million by 2050, the burden of Alzheimer’s and dementia are indisputable. While there are still no approved drugs for the treatment of Alzheimer’s, there… Read More »
Ed Kopetsky, CIO, Stanford Children’s Health/Lucile Packard Children’s Hospital The timing couldn’t have been better. As leaders from the provider, vendor, and policy communities gathered in Washington, D.C. for the CHIME Advocacy Summit, a bill aimed at curbing opioid abuse was passed (quite overwhelmingly) by Senate. The legislation, which now goes to the White House,… Read More »